Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reevax Pharma specializes in patented medical tissue adhesives and wound care solutions. Its flagship products, XOIN and TOPOCRYL (n-butyl cyanoacrylate), are commercial-stage devices used for suture-less closure of wounds and surgical incisions. The company also offers XOIN+, a combination product designed for blocking bleeding gastric varices in gastroenterology applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reevax Pharma.